← Evidence map

ArticleJournal of clinical medicine2026

Sacubitril/Valsartan Improves Functional Capacity and Reverses LV Remodeling in Obese Patients with Hypertrophic HFpEF: A Randomized Open-Label Study.

Artem Ovchinnikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Sacubitril/Valsartan Improves Functional Capacity and Reverses LV Remodeling in Obese Patients with Hypertrophic HFpEF: A Randomized Open-Label Study. | OpenQuestion